Navigation Links
Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
Date:12/20/2007

om time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007 and the quarterly report on Form 10-Q for the quarter ended October 31, 2007. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregrineinc.com Barbara Lindheim

(800) 987-8256 (212) 918-4650


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ll/ - Microbix Biosystems Inc. (the "Company") ann...1 Certification of Annual Filings of William Gastl... Chief Financial Officer (the "Officer,s Certifica...e annual audited financial statements for the year...ally filed the annual financial statements for the...
(Date:11/6/2009)...-- Myriant Technologies LLC ("Myriant"), a private...newable bio-chemicals, Uhde Corporation of America...one of the world,s leading engineering contractors...ngineering, procurement & construction (EPC) o... renewable feedstocks. The execution of this alli...
(Date:11/6/2009)...wswire/ -- Calbiotech, Inc. announced today that i...earch (SBIR) Phase I contract by the U.S. Army Med... the agreement, Calbiotech will develop analyte sp... virus. ,, Dengue virus is a mosquito-born f...ry forces deployed to tropical areas of the world....
(Date:11/6/2009)...Arrowhead’s 2010 Personalized Medicine Partn...February 22-24, 2010 in Philadelphia, has been ann...ight key issues in forming partnerships and engage... Minneapolis, MN (PRWEB) No... 2010 Personalized Medicine Partnerships Conferen...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...ek of August, those seven days in which we attempt...three months. For me, this week also signals the ...ng to San Diego for DEMOmobile 2004. (Its a great ..., youd better do so now.) In truth, I should be p...ductions, but as an inveterate procrastinator, Im ...
...tery to solve. Despite a two-year-plus economic re...ive million jobs (depending on which source you ci...ted. What happened to them why have they not been...s includes high healthcare costs, an inconsistent ...errorism and the war in Iraq, and offshore outsour...
...ce among marketers trying to judge the quality of ...e best-looking web site, but opinions of what cons...eb sites arent based on opinion. They are based on... well-conceived Web sites may vary greatly, good s...hese characteristics provide the basis of the Rese...
Other Biology Technology:Wrapping up the Summer 2Wrapping up the Summer 3Wrapping up the Summer 4Gone missing: Today jobs, tomorrow workers? 2Gone missing: Today jobs, tomorrow workers? 3Governing good Web-site design 2Governing good Web-site design 3
(Date:11/4/2009)...ng Beach and Riverside are responsible for a signi... and the true impact of air pollution and ship emi...ed, according to researchers at the University of ...ppears in an online edition of the American Journ...of all childhood asthma cases in Long Beach and si...
(Date:11/4/2009)...t, hold the power to help militaries and munitions...xic waste on test sites. , Compounds known as ni...World War II and have been used in military muniti...often used to propel tank shells and act like a mo...ed knowledge of their environmentally harmful effe...
(Date:11/4/2009)...ceived more than $10 million in research grants fr...imulus program, bringing thetotal amount of stimul...on. Thirty-three projects achieved stimulus fundi.... , "The university has thoughtfully undertaken ...y excellence to federal agency priorities. Throug...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Systems biology recommended as a clinical approach to cancer 9191 1Systems biology recommended as a clinical approach to cancer 9191 2Connectyx Technologies Holdings Group Inc to Host Nationwide Teleconference Today July 9 2009 3B Company Will Discuss Recent Developments New Par 51216 1Connectyx Technologies Holdings Group Inc to Host Nationwide Teleconference Today July 9 2009 3B Company Will Discuss Recent Developments New Par 51216 2American Heart Association Launches First iPhone Application 3A First Aid and CPR Information Within Pockets Reach 51212 1American Heart Association Launches First iPhone Application 3A First Aid and CPR Information Within Pockets Reach 51212 2
...continued to evolve significantly long after they ...ndertals as they settled across the continent, acc...Proceedings of the National Academy of Sciences (P...y of Bristol, Professor Erik Trinkaus of Washingto... features of an early modern human cranium found i...
...ming most global climate models predict will do mo... observers fear. It will make drastic changes in f... in the Antarctic. , A warming trend during the l...eady forced penguin populations to migrate south a...are at the base of the massive food chain at the b...
...ek’s BMJ raises concerns over whether journal rank...ishing and science. , The impact factor is a measu...ls. It was developed as a simple measure of qualit...ournal to its field. , But a report by the BMJ ...g is distorting the fundamental character of journ...
Other Biology News:40,000-year-old skull shows both modern human and Neandertal traits 2Antarctic warming to reduce animals at base of ecosystem, shift some penguin populations southward 2Are journal rankings distorting science? 2
Goat Anti-cystatin A (N-18) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Afe I from New England Biolabs
...bes is pleased to offer the ATTO-TAG series of rea...amines. Developed by Novotny and collaborators at ...lar to the important reagents o-phthaldialdehyde (...nthracene-2,3-dicarboxaldehyde, all of which are a...
Mouse Anti-Human Troponin I Monoclonal Antibody, Unconjugated, Clone 12F10 from ABR-Affinity BioReagents
Biology Products: